News | September 05, 2024
Emcure Pharmaceuticals launches solution for menopause wellness ‘Arth’ in India
Effective, holistic, science-backed targeted solutions for symptomatic treatment
Effective, holistic, science-backed targeted solutions for symptomatic treatment
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
Ordspono is Regeneron’s first approved bispecific antibody and will provide an off-the-shelf option that can be administered in the out-patient setting, with hope for complete remission
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
Roche confirms that its cobas MPXV test, as well as the LightMix research use only kits, detect the latest mpox virus variants
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
The emergence of new infections in India is a growing concern
Application based on the Transcend FL trial in which Breyanzi showed deep and durable responses and a consistent and well-established safety profile
Subscribe To Our Newsletter & Stay Updated
